The incidence of the mysterious and devastating Alzheimer's disease continues to rise in the U-S. Justin Catanoso, Business Journal contributing writer and director of Wake Forest University's journalism program, discusses a Triad company's new drug with potential to delay the onset of Alzheimer's.
300x250 Ad
300x250 Ad